XML 43 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2021
STOCKHOLDERS' EQUITY  
Summary of activity for stock options

    

    

    

Weighted-

    

average

Weighted-

contractual 

Number of 

 average 

term

Aggregate 

shares

exercise price

(in years)

intrinsic value

Outstanding at January 1, 2019

1,916,900

$

Granted

815,000

6.50

Exercised

Forfeited

(126,170)

6.10

Expired

Outstanding at December 31, 2019

 

2,605,730

$

6.73

8.92

$

11,706,110

Granted

 

75,000

8.21

 

 

Exercised

 

(35,814)

 

4.10

 

 

Forfeited

 

(118,750)

 

10.16

 

 

Expired

 

 

 

Outstanding at December 31, 2020

2,526,166

$

6.99

8.10

$

115,472,832

Granted

Exercised

(52,694)

4.10

Forfeited

(5,935)

4.10

Expired

Outstanding at December 31, 2021

2,467,537

$

7.06

6.99

$

29,503,551

Exercisable at December 31, 2021

 

1,368,106

$

6.57

 

7.05

$

17,023,532

Schedule of Fair Value Assumptions

The fair value of the Company’s option awards were estimated using the assumptions below:

Year Ended

    

December 31, 2021

    

December 31, 2020

 

Volatility

 

0

186.91-191.05

Expected term (in years)

 

0

5.0-6.25

Risk-free rate

 

%

0.34-0.54

%

Expected dividend yield

 

%

%

Schedule of Nonvested Restricted Stock Units Activity

    

    

Weighted-average 

grant date fair 

Number of shares

value

Outstanding at January 1, 2019

 

6,095,692

 

$

8.07

Granted

 

1,851,520

 

12.95

Vested

 

(738,960)

 

9.08

Forfeited

 

(116,463)

 

7.96

Outstanding at December 31, 2019

 

7,091,789

7.78

Granted

 

4,909,829

 

20.34

Vested

 

(1,087,918)

 

8.40

Forfeited

 

(128,666)

 

8.70

Outstanding at December 31, 2020

 

10,785,034

13.38

Granted

2,738,974

39.49

Vested

(1,302,737)

18.14

Forfeited

(189,231)

21.8

Outstanding at December 31, 2021

12,032,040

$

18.67